LCM
PBYI icon

Laurion Capital Management’s Puma Biotechnology PBYI Stock Holding History

Laurion Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-131,175
Closed -$695K – 736
2024
Q1 		$695K Hold
131,175
– – 0.02% 410
2023
Q4 		$568K Buy
+131,175
New +$435K 0.02% 381
2019
Q2 		– Sell
-36,733
Closed -$1.43M – 1159
2019
Q1 		$1.43M Buy
+36,733
New +$1.12M 0.07% 455
2017
Q3 		– Sell
-66,846
Closed -$5.84M – 1865
2017
Q2 		$5.84M Buy
+66,846
New +$3.74M 0.13% 458
2016
Q4 		– Sell
-3,100
Closed -$208K – 1309
2016
Q3 		$208K Buy
+3,100
New +$157K 0.01% 800
2016
Q2 		– Sell
-28,300
Closed -$831K – 1055
2016
Q1 		$831K Buy
+28,300
New +$1.28M 0.07% 457

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return